Introduction
Head and neck squamous cell carcinomas (HNSCCs) account for approximately 5% of all malignancies, with squamous cell carcinoma representing the major histological subtype. While early detection and diagnosis has led to increased survival, the overall 5-year survival rate is still the lowest of all the major cancers investigated to date [1] . Unlike numerous other common carcinomas, including lung, colon, breast and prostate cancers, the molecular pathogenesis underlying HNSCC remains poorly understood [2] [3] [4] .
Head and neck carcinomas mainly originate from the squamous epithelium, in a manner similar to esophageal carcinomas. Patients with HNSCC often develop esophageal carcinomas, while patients with esophageal squa-mous cell carcinoma (ESCC) exhibit a high risk of developing primary cancers in the head and neck regions. These increased risks are thought to be due to environmental factors such as heavy smoking and excessive consumption of alcohol [5] . The histological features of these carcinomas are very similar, and the loss of heterozygosity appears to be a common feature of squamous cell carcinoma that arises in the head and neck, esophagus, lung and urinary bladder [6] [7] [8] [9] [10] . These findings indicate that tumor suppressor genes (TSGs) may be involved in the development of these cancers [2, 11] . One candidate TSG is Deleted in Esophageal Cancer 1 (DEC1) . DEC1 is located on human chromosome 9q32 and is down-regulated in both ESCC cell lines and ESCC tissue specimens [6, 12, 13] . In addition, in vitro colony formation assays and in vivo nude mouse tumorigenicity assays have revealed that DEC1 suppresses esophageal cancer cell growth [12] .
To examine the potential role of DEC1 as an HNSCC candidate TSG, we analyzed DEC1 expression in HNSCC cell lines using real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Histone modifications were also investigated using chromatin immunoprecipitation (ChIP)-quantitative PCR in DEC1 -expressed and -down-regulated HNSCC cell lines. In addition, the motility and invasive ability of the HNSCC cell lines were studied.
Materials and Methods

Cell Culture Conditions
This study analyzed 18 HNSCC cell lines. These cell lines are described in table 1 . HSC2, HSC3, HSC4, HSC5, HSC6, HSC7 , KON and SCCKN cell lines were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). HO-1-N-1 and HO-1-u-1 cell lines were grown in DMEM-F12 medium (1: 1) containing 10% FBS. OSC-19 and OSC-20 cell lines were grown in DMEM-F12 medium (1: 1) in the absence of FBS. The SCC4 cell line was grown in DMEM-F12 medium (1: 1) containing 10% FBS and 0.4 g/ml hydrocortisone. KOSC2-cl3-43, SAT, SAS and SKN3 cell lines were grown in Roswell Park Memorial Institute 1640 medium with 10% FBS. The FaDu cell line was grown in Eagle's Minimum Essential Medium with 10% FBS. NEC1-9, a normal esophageal cell line provided by Y. Shimada [14] , was used as the positive control. NEC1-9 was grown in keratinocyte-SFM supplemented with bovine pituitary extract and epithelial growth factor (Gibco BRL, Life Technologies, Rockville, Md., USA). All media contained 100 IU/ml penicillin and 100 g/ml streptomycin, and all cell lines were grown in a H 2 O-saturated 5% CO 2 atmosphere at 37 ° C.
RNA Extraction
Cell lines were cultured until 80% confluent and harvested. Total RNA was then extracted from the cells using the RNeasy Mini Kit (Qiagen, Valencia, Calif., USA) according to the manufacturer's instructions. Total RNA was treated with RNase-free DNase I (Takara Bio, Shiga, Japan) to remove any contaminating DNA.
Reverse Transcriptase-Polymerase Chain Reaction
Extracted RNA was converted to first-strand cDNA using SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, Calif., USA) and Oligo (dT) 15 primer (Roche, Basel, Switzerland).
The expression levels of DEC1 mRNA were measured with real-time RT-PCR using the LightCycler (Roche). Real-time RT-PCR was performed using Universal Probe Library (UPL) and LightCycler TaqMan Master Mix (Roche). The primers and probe were designed from the UPL Assay Design Center (https://www. roche-applied-science.com/sis/rtpcr/upl/index.jsp). The quantitative RT-PCR primer sequences for DEC1 were: 5 -ACC TGA AAG CAG CCC AGT TA-3 and 5 -GTG CTG GCA CAA TGC TCT T-3 . The UPL probe number was 75. The thermal cycling conditions were as follows: initial denaturation at 95 ° C for 10 min, 45 cycles of 95 ° C for 10 s, 60 ° C for 15 s, and 72 ° C for 1 s. PCR efficiency was calculated from the calibration curve and the threshold cycle numbers (Ct) were determined using the LightCycler Software version 3.5 (Roche). Gene expression values were expressed as the ratio between DEC1 and an internal reference gene, Glucose-6-phosphate 1-dehydrogenase (G6PD) , that was used to normalize the amount of RNA isolated from the cell lines. Each assay was performed in triplicate for each sample.
DEC1 mRNA was confirmed semiquantitatively using a silver stain method with the following primers: 5 -AAG TGG AAG AGC ATT GTG CC-3 and 5 -CTC TGT GCA GGG CAT CAG TA-3 . The reaction conditions were as follows: 95 ° C for 10 min, 
ChIP Assay
We used anti-dimethylated histone H3 K4 (H3K4diM), antidimethylated histone H3 K9 (H3K9diM) and anti-trimethylated histone H3 K27 (H3K27triM, Millipore, Billerica, Mass., USA) antibodies in the ChIP assays. Chromatin was prepared from 1.0 ! 10 6 cells and treated with 1% formaldehyde for 10 min at 37 ° C to crosslink the histones to the DNA. After washing with ice-cold phosphate-buffered saline containing Complete (Roche), the cells were resuspended in SDS lysis buffer with Complete and incubated on ice for 10 min. Lysates were then sonicated with Bioruptor (Cosmo Bio, Tokyo, Japan) for 10 repeats of 30 s to shear the DNA to an average length. The samples were then centrifuged for 10 min at 12,000 rpm at 4 ° C. Sonicated supernatant was diluted 10-fold in ChIP dilution buffer with Complete and 1% of the total was used as an input control. Primary antibodies were then added to the precleared supernatant and incubated for 16 h at 4 ° C. Antibody/histone complexes were then collected by adding 60 l salmon sperm DNA/protein A or G agarose for 1 h at 4 ° C with rotation followed by gentle centrifugation. The protein A or G agarose/antibody/chromatin complex was further washed through a series of wash buffers. Immunocomplexes were eluted and reverse-cross-linked, and immunoprecipitated DNA was recovered by phenol/chloroform extraction and analyzed. Immunoprecipitated DNA products were subjected to quantitative realtime PCR using the primer of promoter region designed to amplify from 500 bp upstream of the DEC1 transcriptional start site. The primer was predesigned and validated using real-time PCR assays by SABiosciences (Frederick, Md., USA). ChIP-qPCR was performed using ChIP-qPCR Primer Assays and RT2 SYBR Green qPCR Master Mix (SABiosciences). The Ct numbers were determined using LightCycler Software version 3.5 (Roche). The histone methylation levels from the ChIP-qPCR assay were calculated using the ⌬ ⌬ Ct method (http://www.sabiosciences.com/ chipqpcr.php).
Migration Assays
Cell migration assays were performed using the CytoSelect Migration and Invasion Assay Kit (Cell Biolabs, San Diego, Calif., USA) according to the manufacturer's instructions. Briefly, the membrane served as a barrier to discriminate between migratory cells and nonmigratory cells. Migratory cells were able to extend protrusions towards chemoattractants and ultimately pass through the pores in the membrane. These migratory cells were then dissociated from the membrane and subsequently detected by CyQuant GR Dye. Fluorescence at 480 nm/520 nm was measured using a fluorescence plate reader.
Invasion Assays
Cell invasion assays were performed using the CytoSelect Migration and Invasion Assay Kit (Cell Biolabs) according to the manufacturer's instructions. Briefly, the upper surface of the insert membrane was coated with a uniform layer of dried basement membrane matrix solution. The basement membrane layer served as a barrier to discriminate between invasive and noninvasive cells. Invasive cells were able to degrade the matrix proteins in the layer, and ultimately pass through the pores of the polycarbonate membrane. Finally, the invading cells were dissociated from the membrane and detected with CyQuant GR Dye.
Results
DEC1 Expression Analysis of Cell Lines
First, we performed real-time RT-PCR to test whether DEC1 is suppressed in HNSCC cell lines compared with its expression in NEC1-9, a normal esophageal cell line. We calculated the ratio of DEC1 / G6PD in each cell line and when the ratio was less than that for NEC1-9, we were able to determine the relative down-regulation of DEC1 ( fig. 1 ) . DEC1 suppression was observed in 12 (66.7%) of 18 cell lines. We cultured an already established normal esophageal cell line, KE2-1 [14] , to confirm our results. We found that the expression level of DEC1 in KE2-1 cells was about the same as in NEC1-9, and the results indicated the same tendency (data not shown). To further confirm our results, we measured the intensity of each PCR band by visualization with silver staining. We calculated the ratio of DEC1 / GAPDH to check the relative down-regulation of DEC1 in the HNSCC cell lines. DEC1 suppression was observed in 10 (55.6%) of 18 HNSCC cell lines compared with NEC1-9 (data not shown). The inconsistency of two cell lines (HSC3 and KOSC2-Cl3-43) may be due to the sensitivity of each methodology. Taken together, our results demonstrate that DEC1 is down-regulated in the majority of HNSCC cell lines examined.
Next, we determined the relationship between DEC1 expression levels and the origin of the cell lines ( fig. 2 ). In particular, DEC1 expression was not detected in four (22.2%) of the HNSCC cell lines (HSC5, HSC7, SCCKN and FaDu). DEC1 down-regulation was detected in 6/8 (75.0%) tongue cancer cell lines, 1/4 (25.0%) oral cavity cancer cell lines and 3/3 (100%) oral floor cancer cell lines. Thus, we found no statistically significant correlation between the relationship of DEC1 down-regulation and the origin of the cell lines.
ChIP-qPCR Assays
DNA hypermethylation is associated with the transcriptional repression of tumor-suppressor and cancerrelated genes [15] . In addition, histone modification is also known to be an important mechanism for the regulation of gene expression. Previous reports have shown that DEC1 promoter hypermethylation is not detected in any of the esophageal cancer samples that have been examined [6] . Thus, we hypothesized that additional epigenetic alterations may contribute to DEC1 down-regulation. To assess the relationship between DEC1 gene expression and histone modification, ChIP-qPCR assay was performed. We used HSC2 and SKN3 as representatives of the DEC1 -expressed HNSCC cell lines and HSC5 and SCC4 as representatives of the DEC1 -down-regulated HNSCC cell lines. As shown in figure 3 a, low H3K27triM in the promoter region was a characteristic of the DEC1-expressed cell lines compared to the DEC1-down-regulated cell lines. There was no obvious decrease at either H3K9diM or H3K4diM ( fig. 3 a, b) . The ChIP-qPCR assay revealed that H3K27triM levels in the promoter region of the DEC1 -down-regulated cell lines were greater than that in the DEC1-expressed cell lines. However, the differences were not significant.
Cell Migration and Invasion Assays
To assess the potential role of DEC1 in HNSCC, we next studied the motility and invasive ability of the HNSCC cell lines. As shown in figure 4 a, cell migration of the DEC1 -expressed cell lines was significantly inhibited compared with that of the DEC1 -down-regulated cell lines (p ! 0.05, t test after logarithmic transformation). However, in the cell invasion assay, no significant differences between the two DEC1 expression profiles were found ( fig. 4 b) . These results indicate that DEC1 may be involved in migration to a greater degree than invasion.
Discussion
Allelic deletions involving 9q occur frequently in tumors derived from squamous epithelium of the head and neck regions, esophagus, lung and urinary bladder [6, 7, 16] . Previous studies have shown that the expression levels of DEC1 , a candidate TSG, were significantly reduced or even lost in ESCC tumors and their associated cell lines [6, 13] . Furthermore, overexpression of DEC1 in ESCC cell lines reduced their tumorigenicity by in vitro colony formation and in in vivo nude mouse assays [12] . In this study, we demonstrated that DEC1 gene expression was down-regulated in 66.7% (12/18) of HNSCC cell lines analyzed. The variation in the levels of DEC1 expression among the different cell lines may have been due to factors such as differences in tumor stage or differentiation status in the tumor cell lines. Our results support the idea that TSGs involved in ESCCs are also responsible for the development of tumors in the head and neck, an important developmental and clinically related tissue. Epigenetic modifications in the promoter region have been shown to be related to the transcriptional regulation of a gene. Above all, histone lysine methylation is regarded as a modification that serves an important function in epigenetic gene control [17] . The methylation of H3 K4, K36 and K79 has been correlated with transcriptional activation, and the methylation of H3 K9, K20 and K27 has been correlated with transcriptional inactivation [18, 19] . Gene inactivation is induced not only by DNA hypermethylation or related H3 K9 methylation, but also by independent H3 K27 methylation. The actual histone modifications that inactivate cancer-related genes differ for each gene. Previous studies have also shown that DEC1 promoter hypermethylation was not detected in any of the esophageal cancer samples examined [6] . The precise epigenetic mechanisms underlying DEC1 gene regulation are yet to be identified. When we compared the histone H3 K4, K9 and K27 methylation levels in HNSCC, we found that the H3K27triM levels in the DEC1 -down-regulated cell lines were higher than that in the expressed cell lines in the promoter region. As described above, H3 K27 and K9 methylation has been correlated with transcriptional inactivation [20] , while H3 K27 methylation has been shown to independently induce gene silencing [21] . It was indicated in this study that histone hypermethylation, especially H3K27triM, was involved in DEC1 down-regulation in the HNSCC cell lines. Furthermore, we examined the expression level of Enhancer of Zeste Homolog 2 ( EZH2 ), the major histone lysine methyltransferase specific to H3 K27 [20, 22] . EZH2 expression was not detected in the four representative cell lines examined, regardless of DEC1 ex- In the migration and invasion assays, the DEC1 -downregulated cell lines tended to be more motile than the DEC1 -expressed cell lines. A previous study has shown no statistically significant differences in the number of migrating and invasive cells between DEC1 stably overexpressed and mock-transfected control cells in vitro cell migration and invasion assays [13] . The findings from that study differ to our results on cell motility. Firstly, this may be due to the difference between ESCC and HNSCC. Secondly, it is also possible that other genes are affecting cell motility. Thirdly, the previous study investigated the cell migration ability of DEC1 stably overexpressed cells and mock-transfected control cells, whereas we examined the cell migration ability of DEC1 -expressed and -down-regulated cell lines. These may be the reasons for the differences observed in cell motility between the previous report and our study.
Patients with HNSCC often develop esophageal carcinomas, while patients with ESCC demonstrate a high risk of developing primary cancer in the head and neck regions. Previous studies have shown that expression of DEC1 was significantly reduced and in some cases lost in ESCC tumors and their associated cell lines. Thus, we hypothesized that DEC1 expression would also be downregulated in HNSCCs. To investigate this hypothesis, we analyzed the expression of DEC1 in HNSCC cell lines.
In conclusion, we have demonstrated that in 66.7% of HNSCC cell lines there is a loss of DEC1 expression, and H3 K27 trimethylation has the potential to play an important role in the regulation of DEC1 expression. Additionally, DEC1 down-regulation tends to contribute to the migration ability of HNSCC cell lines.
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